Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kits EyecareKTYCF -0.79%74 Net Cash per Share is $-0.34 as of Mar. 2026. GuruFocus rates KTYCF with a GF Score™ of 74/100 and a GF Value™ of $10.26 (Fairly Valued). The stock has 1 warning sign investors should review. Among 139 Retail - Cyclical companies, Kits Eyecare ranks worse than 719423.74% on this metric.
The historical rank and industry rank for Kits Eyecare's Net Cash per Share or its related term are showing as below:
During the past 8 years, the highest Price-to-Net-Cash Ratio of Kits Eyecare was 58.93. The lowest was 58.93. And the median was 58.93.
KTYCF's Price-to-Net-Cash is not ranked *
in the Retail - Cyclical industry.
Industry Median: 7.17 * Ranked among companies with meaningful Price-to-Net-Cash only.
Kits Eyecare (OTCPK:KTYCF) Net Cash per Share Explanation
Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.
Kits Eyecare Net Cash per Share Related Terms
Kits Eyecare Net Cash per Share Historical Data
* Premium members only.
The historical data trend for Kits Eyecare's Net Cash per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KTYCF vs CASY, WSM, ULTA: Net Cash per Share Comparison
For the Specialty Retail subindustry, Kits Eyecare's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kits Eyecare Price-to-Net-Cash vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Kits Eyecare's Price-to-Net-Cash distribution charts can be found below:
* The bar in red indicates where Kits Eyecare's Price-to-Net-Cash falls into.
In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.
Kits Eyecare's Net Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kits Eyecare (KTYCF) has a Net Cash per Share of $-0.34 as of Mar. 2026. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Kits Eyecare and its competitors. Over the past decade, Kits Eyecare's Net Cash per Share has ranged from 58.93 to 58.93. According to the industry distribution chart, Kits Eyecare ranks #999999 out of 139 companies in the Retail - Cyclical industry.
Is Kits Eyecare's Net Cash per Share too high?
Kits Eyecare's current Net Cash per Share is $-0.34. Over the past 10 years, this metric has ranged from a low of 58.93 to a high of 58.93. Based on the distribution chart, Kits Eyecare ranks #999999 out of 139 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Kits Eyecare has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kits Eyecare's Net Cash per Share compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Kits Eyecare ranks #999999 out of 139 companies for Net Cash per Share. This places Kits Eyecare in the lower half of its industry. The industry median Net Cash per Share is 7.17. Historically, Kits Eyecare's own Net Cash per Share has ranged from 58.93 to 58.93 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Cash per Share for a Retail - Cyclical company?
The median Net Cash per Share among Retail - Cyclical companies is 7.17, based on 139 companies in the industry. Companies in the top quartile (top 25%) have a Net Cash per Share significantly above this median, while those in the bottom quartile fall well below. However, Net Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Cash per Share mean?
A high Net Cash per Share can signal that a stock is expensive relative to its fundamentals. Net cash per share equals the per-share value of cash and equivalents less total liabilities and minority interest. View historical data on Kits Eyecare and its competitors. For the Retail - Cyclical industry, the median Net Cash per Share is 7.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kits Eyecare's current Net Cash per Share is $-0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kits Eyecare stock overvalued right now?
Based on GuruFocus' analysis, Kits Eyecare (KTYCF) is currently considered Fairly Valued. The stock's GF Value™ is $10.26, compared to a current price of $9.34 — trading 9% below its estimated fair value. The current Net Cash per Share is $-0.34. Kits Eyecare's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Cash per Share calculated?
Net Cash per Share is calculated from a company's financial statements. For Kits Eyecare (KTYCF), the current Net Cash per Share is $-0.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kits Eyecare (KTYCF) Overvalued in 2026?
Based on GuruFocus' analysis, Kits Eyecare stock appears to be undervalued.
The current stock price of $9.34 is trading 9% below its estimated GF Value™ of $10.26.
GuruFocus considers Kits Eyecare to be Fairly Valued.
Key valuation signals for KTYCF:
Net Cash per Share: $-0.34
GF Value™: $10.26 vs. price of $9.34 (9% below fair value)
No single metric tells the full story. See the KTYCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kits Eyecare Ltd is a vertically integrated, digitally native eyecare platform that offers its customers access to a vast selection of the highest quality contact lenses and eyeglasses, including its exclusive KITS-designed products, and a suite of online vision tools. It operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. The company's contact lens partners include Alcon, Bausch & Lomb, CooperVision, and Johnson & Johnson, and its glasses partners include Gucci, Oakley, Prive Revaux, Ray-Ban and Tom Ford. Its geographic locations are the United States; and Canada and Other which generates the majority of its revenue from the United States.
74GF Score
Get the complete analysis for KTYCF
Net Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KTYCF has been successfully added to your 
